Guangzhou Genedenovo Biotechnology Co., Ltd.
PrivateLast Round
Series A
Aug 1, 2016
Est. Valuation
$22.59M
Company Overview
Guangzhou Genedenovo Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Series A round in August 2016.
Guangzhou Genedenovo Biotechnology Co., Ltd. is a biotechnology company that provides high-throughput sequencing and bioinformatics analysis services for academic and clinical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Genedenovo Biotechnology Co., Ltd. Comparables
Compare Guangzhou Genedenovo Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Majorbio Bio-pharm Technology Co., Ltd. | 86% | |
| Shanghai OE Biotech Co., Ltd. | 86% | |
| Beijing Biomarker Technologies Co., Ltd. | 86% |
For institutional investors. Book with your work email.
Guangzhou Genedenovo Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors grew 196% MoM, reaching 11.9K.
- Nov 8, 2025
Monthly visitors increased 77% MoM, reaching 4K.
For institutional investors. Book with your work email.
Guangzhou Genedenovo Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Guangzhou Genedenovo Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Guangzhou Genedenovo Biotechnology Co., Ltd. a public or private company?
Guangzhou Genedenovo Biotechnology Co., Ltd. is a private company.
What is the current stock price of Guangzhou Genedenovo Biotechnology Co., Ltd.?
Guangzhou Genedenovo Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Guangzhou Genedenovo Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Guangzhou Genedenovo Biotechnology Co., Ltd. worth (valuation)?
Guangzhou Genedenovo Biotechnology Co., Ltd.'s valuation is estimated at $22.6M based on funding round data.
Can I buy Guangzhou Genedenovo Biotechnology Co., Ltd. stock?
Guangzhou Genedenovo Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Guangzhou Genedenovo Biotechnology Co., Ltd.'s last funding round?
Guangzhou Genedenovo Biotechnology Co., Ltd.'s most recent funding round was Series A on August 1, 2016.
Who are the main investors in Guangzhou Genedenovo Biotechnology Co., Ltd.?
Investor information for Guangzhou Genedenovo Biotechnology Co., Ltd. is not publicly disclosed.
Will Guangzhou Genedenovo Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangzhou Genedenovo Biotechnology Co., Ltd..
How can I track Guangzhou Genedenovo Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Guangzhou Genedenovo Biotechnology Co., Ltd.'s shares on secondary markets.